Evaluation of the pharmacokinetics and metabolism of a novel histone deacetylase inhibitor, KBH-A40, in rats

Author： Oh S. J.   Lee K.   Ryu J.   Yu H. E.   Han G.   Park S. K.   Kang J. S.   Kim H. M.   Kim Y. C.  

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.41, Iss.2, 2011-02, pp. : 155-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolism as a key to histone deacetylase inhibition

By Rajendran Praveen   Williams David E.   Ho Emily   Dashwood Roderick H.  

Critical Reviews in Biochemistry and Molecular Biology, Vol. 46, Iss. 3, 2011-06 ,pp. : 181-199

Informa Healthcare

Access to resources Recommend Favorite

Metabolism-related liabilities of a potent histone deacetylase (HDAC) inhibitor and relevance of the route of administration on its metabolic fate

By Fonsi M.   Fiore F.   Jones P.   Kinzel O.   Laufer R.   Rowley M.   Monteagudo E.  

Xenobiotica, Vol. 39, Iss. 10, 2009-10 ,pp. : 722-737

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys

By Kuhlmann Olaf   Paehler Axel   Weick Idelette   Funk Christoph   Pantze Michael   Zell Manfred   Timm Uwe  

Xenobiotica, Vol. 40, Iss. 12, 2010-12 ,pp. : 840-852

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Novel Immunomodulators

By  

Current Enzyme Inhibition, Vol. 3, Iss. 3, 2007-08 ,pp. : 207-215

Bentham Science Publishers

Access to resources Recommend Favorite

Transcriptional Activation of p21WAF1/CIP1 by Apicidin, a Novel Histone Deacetylase Inhibitor

By Kim J-S.   Lee S.   Lee T.   Lee Y-W.   Trepel J.B.  

Biochemical and Biophysical Research Communications, Vol. 281, Iss. 4, 2001-03 ,pp. : 866-871

Elsevier

Access to resources Recommend Favorite